The value of alpha-blockers in the management of hypertension: a practical view.
University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow, UK.
G T
GT
McInnes
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000209:etiology; D017292:Doxazosin; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008055:Lipids / Q000097:blood; D011187:Posture; D011224:Prazosin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D012307:Risk Factors; D012907:Smoking
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D008055:Lipids; D017292:Doxazosin; D011224:Prazosin